13F-HR filed by Two Seas Capital LP
Two Seas Capital LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 18 holding rows worth $510,542,668.
- Accession
- 0001315863-24-000464
- Filer
- CIK 1823138
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 18 entries on the cover page, a total value of $510,542,668 stated on the cover page (in dollars after the unit check, H1), rows summing to $510,542,668 with VALUE read as dollars as filed, 13F file number 028-22002. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Indivior PLC | G4766E116 | Common Stock | 13,251,002 | $283,836,474 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 7,930,349 | $83,585,878 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 7,841,927 | $20,232,172 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 541,295 | $17,489,241 | dollars as filed | |
| Esperion Therapeutics Inc | 29664WAB1 | NOTE 4.000%11/15/25 | 20,315,000 | $16,886,844 | dollars as filed | principal |
| META PLATFORMS INC CL A | 30303M102 | COM | 31,958 | $15,518,166 | dollars as filed | |
| VISTRA CORP COM | 92840M102 | Stock | 197,353 | $13,745,636 | dollars as filed | |
| CORE SCIENTIFIC INC NEW | 21874A106 | COM | 3,830,967 | $13,561,623 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 4,165,657 | $11,163,961 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 809,332 | $8,020,480 | dollars as filed | |
| SONOS INC | 83570H108 | COM | 403,653 | $7,693,626 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 318,240 | $5,375,074 | dollars as filed | |
| ODYSSEY MARINE EXPL INC | 676118201 | COM NEW | 1,237,615 | $4,715,313 | dollars as filed | |
| Alphabet Inc. Reg. Shares A | 02079K305 | COM | 24,371 | $3,678,315 | dollars as filed | |
| SOTERA HEALTH CO | 83601L102 | COM | 300,000 | $3,603,000 | dollars as filed | |
| CORE SCIENTIFIC INC NEW | 21874A130 | WTS | 233,540 | $562,831 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 21,891 | $501,304 | dollars as filed | |
| CORE SCIENTIFIC INC NEW | 21874A114 | *W EXP 01/23/202 | 280,248 | $372,730 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001315863-24-000464 | this filing | 2024-05-15 | acceptance time not in the bulk data set |